NASDAQ:TNYA

Tenaya Therapeutics Stock Insider Trading

etoro logo Buy TNYA
*Your capital is at risk
$0.731
+0.0191 (+2.68%)
At Close: Jun 18, 2026

Tenaya Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 83.57. In total, the insiders bought 147.1M and sold 7.89M TNYA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
83.57
Buy 147.1M shares
Sell 7.89M shares
34% Buy Activity
Weak Negative Correlation
Sell Signal Low Confidence
Feb 25, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 83.57.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 28, 2026
Buy
Stock Option (Right to buy)
A-Award
Burroughs Amy L.
Director
Director 120 000
Value: $95.9K
May 28, 2026
Buy
Stock Option (Right to buy)
A-Award
Lee June
Director
Director 120 000
Value: $95.9K
May 28, 2026
Buy
Stock Option (Right to buy)
A-Award
Parschauer Karah Herdman
Director
Director 120 000
Value: $95.9K
May 28, 2026
Buy
Stock Option (Right to buy)
A-Award
Srivastava Deepak
Director
Director 120 000
Value: $95.9K
May 28, 2026
Buy
Stock Option (Right to buy)
A-Award
Stehman-breen Catherine
Director
Director 120 000
Value: $95.9K
May 28, 2026
Buy
Stock Option (Right to buy)
A-Award
Walsh Jeffrey T.
Director
Director 120 000
Value: $95.9K
May 28, 2026
Buy
Stock Option (Right to buy)
A-Award
Williams R Sanders
Director
Director 120 000
Value: $95.9K
May 18, 2026
Sell
Common Stock
S-Sale
Ali Faraz
Chief Executive Officer
CEO / President 3 390
Value: $3K
May 18, 2026
Sell
Common Stock
S-Sale
Tingley Whittemore
Chief Medical Officer
Officer 3 121
Value: $2K
May 18, 2026
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 1 485
Value: $1K
Feb 25, 2026
Sell
Common Stock
S-Sale
Column Group Iii Gp, Lp
10 Percent Owner
10% Owner 1 862 545
Value: $1.05M
Feb 24, 2026
Sell
Common Stock
S-Sale
Column Group Iii Gp, Lp
10 Percent Owner
10% Owner 349 212
Value: $214.9K
Feb 24, 2026
Sell
Common Stock
S-Sale
Column Group Iii Gp, Lp
10 Percent Owner
10% Owner 309 228
Value: $190.3K
Feb 23, 2026
Sell
Common Stock
S-Sale
Column Group Iii Gp, Lp
10 Percent Owner
10% Owner 162 291
Value: $96.9K
Feb 23, 2026
Sell
Common Stock
S-Sale
Column Group Iii Gp, Lp
10 Percent Owner
10% Owner 143 709
Value: $85.8K
Feb 20, 2026
Sell
Common Stock
S-Sale
Column Group Iii Gp, Lp
10 Percent Owner
10% Owner 277 769
Value: $170.8K
Feb 20, 2026
Sell
Common Stock
S-Sale
Column Group Iii Gp, Lp
10 Percent Owner
10% Owner 245 965
Value: $151.2K
Feb 17, 2026
Sell
Common Stock
S-Sale
Tingley Whittemore
Chief Medical Officer
Officer 1 642
Value: $1K
Feb 17, 2026
Sell
Common Stock
S-Sale
Ali Faraz
Chief Executive Officer
CEO / President 5 032
Value: $3K
Feb 17, 2026
Sell
Common Stock
S-Sale
Ali Faraz
Chief Executive Officer
CEO / President 3 979
Value: $3K
Feb 17, 2026
Sell
Common Stock
S-Sale
Ali Faraz
Chief Executive Officer
CEO / President 5 851
Value: $4K
Feb 17, 2026
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 2 022
Value: $1K
Feb 17, 2026
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 836
Value: $538
Feb 17, 2026
Sell
Common Stock
S-Sale
Higa Tomohiro
SVP, Finance
Officer 611
Value: $393
Feb 17, 2026
Sell
Common Stock
S-Sale
Tingley Whittemore
Chief Medical Officer
Officer 1 642
Value: $1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT TENAYA THERAPEUTICS, INC.
Tenaya Therapeutics
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mut...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE